NexGel (NXGL) Stock Price, News & Analysis

Company Overview

NexGel, Inc. (NASDAQ: NXGL) is a development-stage materials science company focused on the research and commercialization of advanced polymer formulations tailored for additive manufacturing and 3D printing applications. Leveraging proprietary expertise in polymer chemistry, NexGel develops high-performance materials designed to meet rigorous mechanical, thermal, and chemical resistance requirements across diverse end markets.

The company’s product pipeline includes custom-engineered resins, powders and elastomeric systems optimized for a range of additive manufacturing processes, including selective laser sintering (SLS), stereolithography (SLA) and fused deposition modeling (FDM). NexGel’s materials aim to enhance part durability, surface finish and functional performance, enabling manufacturers and designers to accelerate prototyping and scale the production of complex components.

Headquartered in the United States, NexGel has pursued strategic partnerships with contract manufacturers, original equipment manufacturers (OEMs) and research institutions to drive material adoption into existing industrial workflows. The company continues to expand its geographic reach and technical capabilities as it works toward broader commercial deployment of its proprietary polymer solutions.

Key Stats

• Today's Range: $2.47 to $2.60
• 50-Day Range: $2.22 to $2.73
• 52-Week Range: $2.10 to $5.10
• Volume: 33,784 shs
• Average Volume: 45,188 shs
• Market Capitalization: $20.42 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NXGL Stock Analysis - Frequently Asked Questions

How have NXGL shares performed this year?

NexGel's stock was trading at $4.46 on January 1st, 2025. Since then, NXGL stock has decreased by 43.3% and is now trading at $2.53.

How were NexGel's earnings last quarter?

NexGel, Inc. (NASDAQ:NXGL) posted its quarterly earnings results on Tuesday, August, 12th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.07) by $0.02. The company earned $2.88 million during the quarter, compared to analysts' expectations of $3.08 million. NexGel had a negative trailing twelve-month return on equity of 49.37% and a negative net margin of 25.02%.
Read the conference call transcript.

When did NexGel IPO?

NexGel (NXGL) raised $14 million in an initial public offering (IPO) on Wednesday, December 22nd 2021. The company issued 2,100,000 shares at a price of $6.83 per share. Maxim Group LLC served as the underwriter for the IPO.

Who are NexGel's major shareholders?

NexGel's top institutional investors include Evernest Financial Advisors LLC (3.67%), IFP Advisors Inc (0.14%) and Malaga Cove Capital LLC (0.14%). Insiders that own company stock include John Nachum Stein, Nachum Stein, Adam R Levy, Steven Mark Glassman, Scott Robert Henry, Adam E Drapczuk III and David Stefansky.
View institutional ownership trends.

How do I buy shares of NexGel?

Shares of NXGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of NexGel own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NexGel investors own include Lexicon Pharmaceuticals (LXRX), Aditxt (ADTX), Helius Medical Technologies (HSDT), Onconova Therapeutics (ONTX), EchoStar (SATS), American Battery Technology (ABML) and Aumann (AAG).

Company Calendar

• Last Earnings: 8/12/2025
• Today: 9/22/2025
• Next Earnings (Estimated): 11/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:NXGL
• CIK: 1468929
• Web: nexgel.com
• Phone: 215-702-8550
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.40)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3.28 million
• Net Margins: -25.02%
• Pretax Margin: -24.82%
• Return on Equity: -49.37%
• Return on Assets: -25.68%

Debt

• Debt-to-Equity Ratio: 0.16
• Current Ratio: 1.74
• Quick Ratio: 0.98

Sales & Book Value

• Annual Sales: $8.69 million
• Price / Sales: 2.35
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.90 per share
• Price / Book: 2.81

Miscellaneous

• Outstanding Shares: 8,070,000
• Free Float: 6,410,000
• Market Cap: $20.42 million
• Optionable: Not Optionable
• Beta: 0.58